The driving force behind most conjugated linoleic acid (CLA) research in swine has been related to potential improvements in animal production. Early work that used rodent models indicated that feeding CLA could potentially reduce body fat, increase lean content, increase growth rate, and improve feed conversion efficiency. Producer-backed funding organizations were, therefore, receptive to proposals to extend this research to pigs, and many studies have been completed worldwide. In general, improvements in body composition were found, but evidence indicating that CLA improves growth rate or feed conversion was limited.
INTRODUCTION
Pigs are monogastric animals, and their stomach contains few microorganisms relative to ruminant animals (eg, cattle). In addition, stomach contents in pigs have a greater rate of passage relative to ruminants, and this rate of passage further limits the potential for gastric hydrogenation of fatty acids and the production of conjugated linoleic acid (CLA). Consequently, only a small amount of CLA is produced by way of bacterial biohydrogenation in pigs, and pork usually contains a limited amount of CLA (0.1-0.2 mg/g fatty acids). Pork, however, is an ideal candidate for CLA enrichment by feeding synthetic CLA, because CLA will not be further saturated before absorption, CLA deposits in tissues with relatively high efficiency, and pork could become a physiologically significant source of CLA for human consumption.
Initial reasons for feeding CLA to pigs relate to early rodent work (1, 2) , indicating that CLA has the potential to reduce body fat, increase lean, increase growth rate, and improve feed conversion efficiency. When feed-grade CLA became available in 1996 -1997, funding was requested from pork producer groups to determine whether CLA could improve production economics by improving animal performance and carcass composition and also to determine whether CLA would affect any aspect of pork quality. To date there are roughly 33 articles published that involve feeding CLA to pigs. Eight articles are mechanistic in nature (ie, studying how CLA might work) (3-11), 4 are related to CLA's potential to improve immune status (12) (13) (14) (15) , and the remaining 18 (16 -33) are related to CLA's effects on pig performance, body composition, and pork quality.
ANIMAL PERFORMANCE AND CARCASS COMPOSITION
The weights of animals at the start and finish of tests in the 18 studies to be considered are listed in Table 1 . Of the 18 studies, only 14 (16 -22, 24 -26, 28, 30 -32) reported animal performance results (growth rates and feed conversions efficiency). Of those 14 studies, 2 included animals finishing at light weights (16, 17) and 2 studies included animals starting at heavier weights (31, 32) , and these studies showed no effect of CLA on animal performance or carcass composition. Perhaps these animals were removed from test too early or started on test too late to see a response to CLA. Gatlin et al (31) apparently started feeding at a heavy weight according to days on test and feed conversion results. O'Quinn et al (22) conducted 2 trials with CLA; the first trial showed no effect, but the second trial, with tall oil as the source of CLA, showed effects. Of the remaining 10 studies, feed conversion efficiency (kilogram feed per kilogram gain) was improved in 7 cases by an average of 6.5%, but only one showed an improvement (8.2%) in average daily gain ( Table 2) .
By excluding the studies that indicated finishing or starting on test at light or heavy weights (16, 17, 31, 32) , 12 studies reported carcass fat amounts with 11 showing reductions (18 -22, 24 -28, 30) , and 10 studies reported carcass lean with 9 showing increases (18 -23, 25, 26, 28) . Changes in fat content were greater on a percentage basis relative to lean, and results for both were quite variable. Fat reduction ranged from 6.2% to 25%, and lean increase ranged from 2.3% to 9.7%. Some of this variation was likely due to the measurements taken to approximate carcass composition. For lean content, a number of measures were used, including loin depth, loin area by tracing, loin area by ultrasound, loin weight, gram lean per kilogram sellable cuts, and proximate analysis of carcass sides. For fat measurements, 8 studies reported backfat depths, and 4 studies reported either actual fat mass by dissection or by chemical analysis.
Backfat and lean depths are used to calculate lean yield for price settlements (ie, producers get paid for lean and packers do not pay for extra carcass fat). The use of depth measurements is, however, relatively insensitive for detecting changes in lean genetic stock. This simple measurement is used commercially because carcass line speeds can be up to 8 pigs/min or faster, and, at 1 carcass every 7 s, only a limited number of minimally invasive measurements are possible.
As an example, data gathered in the same experiment but not reported in Dugan et al (28) showed poor agreement between estimated lean yield (from fat and lean depths) and actual lean yield (from carcass dissection) (Figure 1) . Consequently, the increase in estimated lean yield (0.7%) was not significant, but the actual increase in lean yield (1.9%) by carcass dissection was significant. In addition, the reduction in backfat depth was not significant (Ҁ4.6%), but the actual reduction in fat mass (g/kg sellable lean cuts) was significant (Ҁ6.8%). Between trial variability could, in part, be explained by methods used, but further investigation into a number of variables (eg, breed, sex, diet interactions, CLA composition and level in diet, duration, and weight range of feeding) is needed to enable a full explanation. In addition, concurrent studies are necessary to further establish the mechanisms of CLA action and how these mechanisms could be further manipulated.
QUANTITY AND COMPOSITION OF THE CONJUGATED LINOLEIC ACID FED
In 14 studies, pigs were fed CLA that contained at least the 4 common cis/trans isomers (trans-8,cis-10; cis-9,trans-11; trans-10,cis-12; cis-11,trans-13), and in 2-3 studies pigs were fed 2 isomer preparations (trans-10,cis-12; cis-9,trans-11). Most of the CLA was in free fatty acid form. The CLA content of the CLA oil included in the diets averaged 69%. With the assumption that feed intake was 2.7 kg/d, CLA intake ranged from 3.4 to 135 g/d (Table 3) , and the median amount consumed was 27.3 g/d. In contrast, Gaullier et al (34) reviewed 16 human trials; the median CLA consumption was 3.4 g/d, and 3.4 g/d appeared to be the threshold for showing effects on human body composition. Interestingly, the 2 pig studies feeding CLA at 3.4 g/d did not show any changes in body composition.
PORK QUALITY
Pork quality was initially investigated to determine whether feeding CLA would have a negative effect (29) . In that study, a number of loin quality indexes were unaffected by CLA, and most have now been supported by other researchers ( Table 4) . The initial report (29) also indicated CLA increased both loin marbling scores and solvent extractable intramuscular fat amounts (3.8 g/kg loin). These results have now been supported by 3 studies (20, 24, 33) , but 2 studies (18, 27) have shown no change. Interestingly, the subcutaneous fat depot has been consistently reduced by feeding CLA, but the intramuscular depot has shown signs of increasing. Potentially the difference in maturity of adipocytes in these depots could play a role in these phenomena. The subcutaneous fat depot is relatively mature, and the intramuscular depot contains a high proportion of preadipocytes that could be stimulated by CLA to mature and start to deposit triacylglycerol (6) .
After the report of Lee et al (35) indicating that CLA inhibited ⌬ 9 -desaturase activity, there have been 8 reports that indicate CLA increases the amount of saturates in pig tissues (10, 17, 19, 20, 22, (31) (32) (33) . Greater fatty acid saturation means firmer bellies and loins, as well as fewer problems with bacon slicing and sausage making. This characteristic can be of particular importance with elevated dietary oil or when pigs are very lean. Increased belly firmness was reported in 3 studies (19, 22, 32) , CLA had no effect in 1 study (23), and 2 reports indicated CLA increases loin muscle oxidative stability (20, 33) .
IS THERE VALUE IN THE PIG BARN?
The next obvious step in realizing CLA's potential is being able to market CLA-enriched pork and pork products. Eggs enriched with nҀ3 fatty acids are marketed at prices 50 -100% greater than normal eggs, and the same potential could be possible for fatty acid-enriched pork and pork products. Pigs have the advantage, relative to ruminants, of being able to ingest fatty acids and deposit them with relatively high efficiency, and some fairly impressive enrichments can result ( Table 5) CLA content of loin muscle ranged from 0.71% to 2.8% of fatty acids, and CLA in subcutaneous fat ranged from 1.7% to 9.5% of fatty acids. Ramsay et al (17) reported the greatest CLA enrichment with 2.8% in loin fatty acids and 9.5% in subcutaneous fatty acids. They fed 0%, 0.25%, 0.5%, and 2% dietary CLA, and the CLA oil was reported to have 25% cis-9,trans-11 and 35% cis-10,trans-12 CLA. In addition, pigs were only fed from 20 to 50 kg. Ramsay et al (17) showed that with increasing dietary CLA, backfat CLA increased. In addition, with increasing dietary CLA, the trans-10,cis-12:cis-9,trans-11 CLA increased. The CLA amounts were Ȃ2 times what would be expected in finished (110 kg) animals fed a similar amount of CLA. Higher CLA in tissues might, therefore, explain why feed conversion was enhanced earlier in a number of studies and could also explain why animals starting at heavier weights might be less responsive to dietary CLA.
How much pork or pork products would a person then have to eat daily to see an effect? As stated previously, 3.4 g/d of CLA was suggest by Gaullier et al (34) to be the threshold needed to see changes in body composition. This amount might not, however, be the amount needed to see other metabolic effects (eg, as an (27) 13.5 ----Dugan et al (28, 29) 54.0 ----Dunshea et al (30) 10.8 ----Gatlin et al (31) 27.0 ----Eggert et al (32) 27.0 ----Joo et al (33) 27.0 67.5 135.0 --anticarcinogen). If it were, however, found that 3.4 g of CLA needed to be consumed to provide beneficial effects, then substantial quantities of pork (2 kg) would need to be consumed per day to satisfy this requirement (assuming pork contained 5% fat and had 3% CLA in the fat). This amount would be impractical, unless part of the requirement could be satisfied by consuming other CLA-enriched products (eg, dairy or beef). Alternatively, if highly enriched subcutaneous fat from pigs (ie, containing Ȃ10% CLA) could be used to produce pork sausages or lard for baked products, a daily dose of CLA might be obtained by consuming 3-4 sausage links (25% fat) or by eating about 15 cookies (20% fat).
TAKING CONJUGATED LINOLEIC ACID-ENRICHED PORK TO MARKET
The first step in being able to bring CLA-enriched pork to market is getting approval for adding CLA to animal diets. BASF holds the international license to add CLA to animal feed and has applied for permission to do so in Canada and the United States, but approval has not been granted thus far. Step 2 will be to apply for approval to advertise CLA enrichments in pork, and applications will certainly require documentation that indicates why CLA enrichment would be beneficial for the public. At present, fatty acid (nҀ3)-enriched meats or meat products are not available in Canada but are available in other parts of the world (eg, Korea). Vertical integration or producer/packer alliances will likely be key factors in bringing CLA-enriched pork to market in North America. The cost of feeding CLA, the amounts of CLA needed to see a desired effect, and what consumers are willing to pay for CLA-enriched products will, however, ultimately determine whether CLA-enriched products can be marketed successfully.
SUMMARY
Feeding CLA to pigs has the potential to improve animal performance, carcass composition, and pork quality and to provide CLA-enriched pork for human consumption. Variations in CLA responses and enrichments still need to be addressed, but uniform production practices and vertical integration from production through marketing could very well bring CLA-enriched pork to market. Regulatory issues concerning the addition of CLA to animal feeds and the ability to claim CLA enrichments would, however, need to be addressed before enriched products can be marketed. In addition, it needs to be determined how profitable it would be to feed CLA to pigs to provide enriched pork and pork products beneficial to the consumer.
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